Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus

Vaccine

Volumn 26, Issue 9, 2008, Pages 1235-1242

  Dortmans, J C F M ^a   Loeffen, W L A ^a   Weerdmeester, K ^a   van der Poel, W H M ^a   de Bruin, M G M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Classical swine fever virus; Horizontal transmission; Intradermal vaccination; Intramuscular vaccination; Subunit vaccine

Indexed keywords

GLYCOPROTEIN E2; MARKER VACCINE; OIL; WATER;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; NONHUMAN; PESTIVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; DISEASE TRANSMISSION, HORIZONTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INJECTIONS, INTRAMUSCULAR; POLYMERASE CHAIN REACTION; SWINE; TREATMENT OUTCOME; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 39149108792     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.039     Document Type: Article

References (32)

1. Reimann I., Depner K., Trapp S., and Beer M. An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322 1 (2004) 143-157
2. De Jong M.C., and Kimman T.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine 12 8 (1994) 761-766
3. Dewulf J., Laevens H., Koenen F., Mintiens K., and de Kruif A. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Prev Vet Med 65 3-4 (2004) 121-133
4. Hunsaker B.D., and Perino L.J. Efficacy of intradermal vaccination. Vet Immunol Immunopathol 79 1-2 (2001) 1-13
5. van Gennip H.G., Bouma A., van Rijn P.A., Widjojoatmodjo M.N., and Moormann R.J. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. Vaccine 20 11-12 (2002) 1544-1556
6. Mikulska-Skupien E., Szweda W., Procajlo Z., and Platt-Samoraj A. Indices of non-specific cellular immune response in pigs after intradermal vaccination with deleted Aujeszky's disease vaccine and after experimental infection. Bull Vet Inst Pulawy 48 (2004) 347-354
7. Lodmell D.L., Ewalt L.C., Parnell M.J., Rupprecht C.E., and Hanlon C.A. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus. Vaccine 24 4 (2006) 412-416
8. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 22 (2004) 2286-2294
9. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 22 (2004) 2295-2301
10. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 96 4 (2003) 367-384
11. Greiser-Wilke I., Depner K., Fritzemeier J., Haas L., and Moennig V. Application of a computer program for genetic typing of classical swine fever virus isolates from Germany. J Virol Methods 75 2 (1998) 141-150
12. Widjojoatmodjo M.N., van Gennip H.G., de Smit A.J., and Moormann R.J. Comparative sequence analysis of classical swine fever virus isolates from the epizootic in The Netherlands in 1997-1998. Vet Microbiol 66 4 (1999) 291-299
13. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., and De Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 73 2-3 (2000) 209-219
14. Bouma A., De Smit A.J., De Jong M.C., De Kluijver E.P., and Moormann R.J. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 18 14 (2000) 1374-1381
15. Wensvoort G., Terpstra C., Boonstra J., Bloemraad M., and Van Zaane D. Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis. Vet Microbiol 12 2 (1986) 101-108
16. Terpstra C., Bloemraad M., and Gielkens A.L. The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Vet Microbiol 9 2 (1984) 113-120
17. Reed L.J., and Muench H.A. A simple method of estimating fifty per cent endpoints. Am J Trop Med Hyg 27 (1938) 493-497
18. Ressang A.A., and Den Boer J.L. A comparison between the cell culture, frozen tissue section and mucosal smear technique for fluorescent antibody in the diagnosis of hog cholera. Tijdschr Diergeneeskd 92 (1967) 567-586
19. van der Goot J.A., Koch G., de Jong M.C., and van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci USA 102 50 (2005) 18141-18146
20. Kroese A.H., and de Jong M.C.M. Design and analysis of transmission experiments. In: Menzies F.D., and Reid S.W.J. (Eds). Proceedings of the society for veterinary epidemiology and preventive medicine. Noordwijkerhout, The Netherlands (March 28-30, 2001) 21-37
21. Melkebeek V., Verdonck F., Stuyven E., Goddeeris B., and Cox E. Plasmid-encoded GM-CSF induces priming of the F4(K88)-specific serum IgA response by FaeG DNA vaccination in pigs. Vaccine 24 21 (2006) 4592-4594
22. van Rooij E.M., Haagmans B.L., de Visser Y.E., de Bruin M.G., Boersma W., and Bianchi A.T. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol 66 2 (1998) 113-126
23. Maurer R., Stettler P., Ruggli N., Hofmann M.A., and Tratschin J.D. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine 23 25 (2005) 3318-3328
24. Vanderpooten A., Goddeeris B., De Roose P., Hendrickx L., Biront P., and Desmettre P. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs. Vet Microbiol 55 1-4 (1997) 81-89
25. Gerdts V., Jons A., and Mettenleiter T.C. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs. Vet Microbiol 66 1 (1999) 1-13
26. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol 32 6 (2003) 567-582
27. Vannier P., and Cariolet R. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines. Vet Microbiol 26 1-2 (1991) 11-23
28. Mayer D., Hofmann M.A., and Tratschin J.D. Attenuation of classical swine fever virus by deletion of the viral N(pro) gene. Vaccine 22 3-4 (2004) 317-328
29. de Smit A.J., Bouma A., van Gennip H.G., de Kluijver E.P., and Moormann R.J. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine 19 11-12 (2001) 1467-1476
30. Widjojoatmodjo M.N., van Gennip H.G., Bouma A., van Rijn P.A., and Moormann R.J. Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines. J Virol 74 7 (2000) 2973-2980
31. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., and Moormann R.J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 19 4-5 (2000) 447-459
32. Uttenthal A., Le Potier M.F., Romero L., De Mia G.M., and Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs. Vet Microbiol 83 2 (2001) 85-106